Review
Open access
Aug 2026
From PEG to randomized PEG: a macromolecular strategy tackling PEG immunogenicity.
Reduced antigenicity of rPEG was confirmed via ELISA, MST, and FCS analysis, and in vitro studies demonstrated that rPEG is noncytotoxic, does not interact with blood, and is unlikely to activate complement, and rPEG represents a highly promising PEG alternative.
Julian Schmidt, Caroline Bockhard, Lea Simon et al.
· Advanced Drug Delivery Revie... · 1 citation